Intrathecal immune activation in three patients with progressive myoclonic ataxia
✍ Scribed by A. Salmaggi; F. Carella; C. Ciano; S. Binelli; P. Giovannini; E. Palazzini; Dr. F. Girotti
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 321 KB
- Volume
- 10
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Three patients displaying a clinical picture of progressively evolving multifocal action myoclonus and cerebellar ataxia showed a marked intrathecal immune activation, which was persistent over a 2‐ to 5‐year time span in the two serially investigated patients. A thorough search for metabolic, toxic, infectious, or degenerative causes of myoclonus was unsuccessful. The presence of intrathecal immune activation in at least a subgroup of patients with the clinical features of progressive myoclonic ataxia suggests the possibility of immune‐mediated damage within the central nervous system in this condition.
📜 SIMILAR VOLUMES
## Objective: To determine whether treatment with leflunomide (lef), methotrexate (mtx), or sulfasalazine (ssz) for 6-12 months retards progression of radiographic damage and to identify clinical variables that correlate with radiographic progression. ## Methods: Radiographs of the hands and feet